One key to your high blood pressure might just be your inflammatory genes. It may sound odd but mounting evidence suggests that inflammation, a part of the immune response implicated in diseases such as cancer, Alzheimer’s and diabetes, may also help translate stress into high blood pressure.
A common perception is that pet owner is a young person who is full of action, exercises a lot, and actively plays with a pet, particularly with a dog. The reality is different, however.
By age 10, some black children already have high nighttime blood pressure, an early signal of impending cardiovascular disease, a new study shows.
Fat zapping to shed excess weight, miniature telescopes to restore vision, and smart nappies to detect common childhood infections — these are some of the new technologies that promise to transform medicine, according to this week’s Christmas issue of the BMJ.
The Institute of Medicine estimates that medical errors are the eighth leading cause of death in the United States, and poor communication can be a major source of those errors. Now the Clinical Simulation Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis hopes to improve patient safety by using clinical simulators to find the source of miscommunications during medical treatments.
Whether reopening narrowed kidney arteries benefits patients is a $1.7 billion question a North American study hopes to answer.
Symptoms of heart disease and diabetes usually seen in adults are increasingly being found in adolescents according to a longitudinal study, which suggests that reducing the intake of sugar-sweetened beverages during childhood may lessen the risk of chronic disease in later life.
Biophan Technologies, Inc., a developer of next-generation medical technology, in conjunction with MYOTECH, LLC, recently presented results of animal studies that indicate the potential of the MYO-VAD, a cardiac support system to significantly improve the treatment of heart failure. The MYO-VAD restores cardiac output on an arrested or weak heart. The device can be implanted in approximately three minutes.
The U.S. Food and Drug Administration (FDA) today approved Celebrex (celecoxib) for a new use ? the relief of the signs and symptoms of Juvenile Rheumatoid Arthritis (JRA) in patients two years of age and older. Today’s approval follows the November 29 meeting of FDA’s Arthritis Advisory Committee, in which the committee voted 15 to 1 in favor of approval of this product.
The Food and Drug Administration (FDA) today approved Cyanokit (containing the drug hydroxocobalamin, intravenous tubing and a sterile spike for reconstituting the drug product with saline) for the treatment of known or suspected cyanide poisoning. The approval, which is based on evidence of the drug’s effectiveness when tested in animals, improves the nation’s ability to respond to emergencies, including a potential attack by terrorists.